Neuren Pharmaceuticals | NEU - Eps Gewinn Pro Aktie

Aktienkurs
12.27
Täglich Wechseln
0.34 2.85%
Monatlich
5.50%
Jährlich
5.23%
Q2 Prognose
12.10




Eps Veränderung Datum
Akebia Therapeutics USD -0.04 0.04 2025-12
Alaunos Therapeutics USD -0.53 0.08 2025-09
Avita Medical AUD -0.38 0 2025-12
Clinuvel Pharmaceuticals AUD 0.21 0.23 2025-12
Dianthus Therapeutics USD -1.43 0.46 2025-12
Genetic Signatures AUD -0.03 0.02 2025-12
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Medical Developments International AUD 0 0 2025-12
Neuren Pharmaceuticals AUD 0.12 0.06 2025-12
Organon & Co USD 0.63 0.38 2025-12
Paradigm Biopharmaceuticals AUD -0.06 0.03 2025-12
PYC Therapeutics AUD -0.04 0.01 2025-12
Starpharma Holdings AUD 0 0.01 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Telix Pharmaceuticals AUD -0.05 0.33 2025-12
Viatris USD 0.57 0.1 2025-12
Xeris Pharmaceuticals USD 0.05 0.05 2025-12